Skip to main content
. 2021 Nov 8;16(1):5. doi: 10.3892/mco.2021.2438

Table I.

Summary of the clinicopathological features of Warthin-like mucoepidermoid carcinoma.

Authors (year) Age, years/sex Chief complaint Location Duration (months) Treatment Adjuvant (months) Follow-up (months) Disease status MAML2 fusions Metastasis FNA (Refs.)
Ishibashi et al (2015) 23/F NA Parotid 1 Resection NA 120 NED Positive No NA (3)
Ishibashi et al (2015) 23/F NA Parotid 120 Resection NA 36 NED Positive No NA (3)
Ishibashi et al (2015) 33/F NA Parotid NA Resection NA 96 NED Positive No NA (3)
Ishibashi et al (2015) 46/F NA Parotid 24 Resection NA 120 NED Positive No NA (3)
Ishibashi et al (2015) 60/F NA Parotid 240 Resection NA 12 NED Positive No NA (3)
Hang et al (2017) 53/F Painlessmass Parotid NA Superficial parotidectomy None NA NA Positive No Done (10)
Hang et al (2017) 53/F Painlessmass Parotid 12 Parotidectomy None NA NA Positive No Done (10)
Heatley et al (2018) 17/F Painlessmass Parotid NA Resection NA 48 LR Not done No NA (13)
Bishop et al (2018) 42/M, 33/F, 53/F, 51/M, 51/F, 53/F NA Parotid NA Resection (2 cases) NA (4 cases) NA 7 and 20 months (each case) NED (2 cases) Positive No NA (14)
Akaev et al (2018) 53/F Painlessmass Parotid NA Superficial parotidectomy NA 14 NED Positive No Done (11)
Balasubiramaniyan et al (2019) 56/F Painlessmass Parotid 2 Superficial parotidectomy None 12 NED Not done No Done (9)
Zhang et al (2019) 36/M Painlessmass Parotid 3 Parotidectomy None 12 NED Positive No Done (8)
Daoud et al (2020) 13/F Painlessmass Parotid 12 Resection None 22 NED Positive No NA (15)
Daoud et al (2020) 14/M Painlessmass Parotid 3 Resection Proton therapy (4) 30 LR Positive No NA (15)
Bieńkowski et al (2020) 30/F Painlessmass Parotid 6 Resection None NA NED Positive No NA (12)
Bieńkowski et al (2020) 51/F Painlessmass Parotid 84 Resection None NA NA Positive No ND (12)
Present case 16/F Painfulmass Parotid 2 Superficial parotidectomy None 6 NED Positive No Done /

F, female; FNA, fine-needle aspiration; LR, local recurrence; M, male; NA, not available; ND, no diagnostic material included; NED, no evidence of disease; MAML2, mastermind-like transcriptional coactivator 2.